Digital Pathology Market - By Product (Image Analysis Software, Scanner, Services), Application (Drug Discovery & Development, Disease Diagnosis, Teleconsultation), End-use (Hospital, Biotech & Pharma Companies, Diagnostic Laboratories, Research Institutes) – Global Forecast, 2024-2032

Digital Pathology Market - By Product (Image Analysis Software, Scanner, Services), Application (Drug Discovery & Development, Disease Diagnosis, Teleconsultation), End-use (Hospital, Biotech & Pharma Companies, Diagnostic Laboratories, Research Institutes) – Global Forecast, 2024-2032

Digital Pathology Market Size

Digital Pathology Market size was valued at USD 1 billion in 2023 and is anticipated to register a CAGR of over 11% between 2024 and 2032. Digital pathology is a sub-field of pathology that focuses on data management based on information generated from digitized specimen slides.

It incorporates the acquisition, management, sharing, and interpretation of pathological information, including slides and data, in a digital environment. The healthcare sector's growing adoption of digital pathology is a significant driving force behind the market's expansion. According to a survey, nearly 70% of life sciences organizations surveyed have already adopted digital pathology.

The increasing adoption of digital pathology is revolutionizing the field of pathology by enhancing lab efficiency. This efficiency includes faster diagnoses enabled by remote slide analysis, increased diagnostic accuracy, and reduction in number of manual errors. The adoption of digital pathology offers healthcare institutions compelling cost-saving advantages through reduction of expenses related to storage and transportation of physical slides, as well as the need for additional staff to manage these slides.

COVID-19 Impact

COVID-19 pandemic had a positive impact on the digital pathology market. It also accelerated the adoption of remote patient monitoring devices. During the initial stages of pandemic challenges related to implementation and supply chain disruptions were witnessed signifying the need to remote diagnostics. However, the overall trajectory for digital pathology remained positive owing to its enhanced application for optimal diagnostics and remote accessibility during the COVID-19. Therefore, the pandemic significantly heightened the growth dynamics of the market for digital pathology.
 

Digital Pathology Market Trends

Electronic Health Record (EHR) valued at over 62.5 billion in 2022, have the potential to improve patient care by making the diagnosis and monitoring of disease much more efficient through the integration of digital pathology systems. The advantages of EHRs and digital pathology can be combined to provide a comprehensive view of the patient's disease process, enabling faster and accurate diagnosis. However, there are also challenges to overcome, such as the lack of labelled data and affordability of required computational expenses.
 

• Also, digital pathology systems enable pathologists to access high-resolution images remotely, facilitating quick and accurate diagnoses
   
• With ongoing advancements in AI and telepathology, the future holds even greater promise for this integration, ultimately contributing to better healthcare outcomes and patient experiences.
   
• Integrating these systems with EHRs ensures that pathologists will have access to comprehensive patient histories, test results, and other relevant data, all readily available. Therefore, these aforementioned factors hold significant potential for market growth.
   

Digital Pathology Market Analysis

The market by product is categorized into image analysis software, scanner, and services. The scanner segment garnered USD 496 million revenue size in the year 2022. The scanner segmented is further bifurcated into bright field scanner, fluorescence scanner, combination scanner and others. The increasing demand for combination scanners in digital pathology is propelling market growth due to their versatility, workflow efficiency, and improved diagnostic accuracy.
 

• These devices are at the forefront of technological advancements, enabling a seamless integration of digital pathology into healthcare systems and enhancing patient care.
   
• As digital pathology continues to evolve, combination scanners will play a pivotal role in shaping the future of pathology and contributing to better healthcare outcomes.
   

Based on application, the digital pathology market is segmented into drug discovery & development, disease diagnosis, teleconsultation, and others. The disease diagnosis segment accounted for over 40% business share in the year 2022. High segment share is attributed to higher incidence of relevant diseases and the pressing need for rapid diagnostics.

• According to WHO, by 2030, the proportion of total global deaths due to chronic diseases is expected to increase to 70% indicating the need for faster diagnostic tools. This will lead to escalated adoption of digital pathology to provide faster and more accurate diagnosis.
   
• The integration of digital pathology with EHRs can also improve workflow management by eliminating the need for physical transport of slides and reducing the time required for slide preparation.
   

Overall, the adoption of digital pathology is expected to bring significant benefits to pathology labs, including increased efficiency, accuracy, and cost savings, which can help manage healthcare resources more efficiently.
 

The digital pathology market by end-use is categorized into hospitals, biotech & pharma companies, diagnostic laboratories, academic & research institutes, and others. The diagnostic laboratories segment garnered USD 261 million revenue size in the year 2022.
 

• The adoption of digital pathology in these laboratories has proven instrumental in streamlining processes and enhancing the overall efficiency of diagnostic workflows.
   
• Through the digitization of glass slides into high-resolution whole-slide images, pathologists and laboratory technicians can access and analyze patient samples remotely, reducing turnaround time and minimizing the errors associated with traditional microscopy.
   
• The growing demand for digital pathology by diagnostic laboratories reflects a commitment to advancing diagnostic accuracy, efficiency, and patient outcomes in the ever-evolving landscape of modern healthcare.
   

U.S. digital pathology market accounted for USD 152 million revenue size in 2022 and is predicted to witness substantial market growth during the analysis timeline.

• With the growing importance of technology and data-driven healthcare solutions, digital pathology has gained prominence as a transformative force in pathology and diagnostics in the country.
   
• Furthermore, the U.S. market has been driven by the rising prevalence of chronic diseases, the need for more efficient diagnostic processes, and the integration of these systems with EHR and Laboratory Information Management System (LIMS).
   

Digital Pathology Market Share

The digital pathology industry is consolidated, with major players such as Danaher Corporation, Koninklijke Philips N.V, F. Hoffmann-La Roche Ltd., and others dominating the market. These companies are focused on continuous product innovation to secure a significant market share. For instance, in 2022, Danaher Corporation collaborated with Indica Labs to ensure seamless integration of digital pathology workflow solutions, enabling file compatibility between the Leica Biosystems Aperio GT 450 scanner series and Indica Labs' Halo software solutions.
 

Some of the eminent market participants operating in the digital pathology industry include

• 3DHISTECH LTD
•  Danaher Corporation
•  Glencoe Software Inc.
•  HAMAMTSU Photonics K.K
•  Indica Labs Inc.
•  Koninklijke Philips N.V
•  Nikon Corporation
•  Perkinelmer Inc.
• F. Hoffmann-La Roche Ltd 
•  VisoPharma A/S.
• Olympus Corporation
• Leica Biosystems
• Proscia Inc.
• Mikroscan Technologies Inc
• Sectra AG
   

Digital Pathology Industry News

• In March 2023, Leica Biosystems unveiled an expanded partnership with Paige, aimed at advancing AI and image management technologies within the global landscape of digital pathology workflow.
   
• In June 2022, Roche introduced the VENTANA DP 600 slide scanner, designed to enhance patient care through precision diagnostics in digital pathology. This high-capacity slide scanner is capable of generating high-resolution digital images of stained tissue samples, thereby aiding in the accurate diagnosis of cancer and the selection of appropriate treatment strategies.
   

 Digital pathology market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

 

By Product, 2018-2032 (USD Million)

• Image analysis software     
  • On-premise
  • Cloud-based
• Scanner
  • Bright field scanner
  • Fluorescence scanner
  • Combination scanner
  • Other scanners
• Services
  • Installation and integration
  • Maintenance services
  • Consulting services

By Application, 2018-2032 (USD Million)

• Drug discovery & development
• Disease diagnosis
• Teleconsultation
• Other applications

By End-use, 2018-2032 (USD Million)

• Hospitals
• Biotech & pharma companies
• Diagnostic laboratories
• Academic & research institutes
• Other end-users

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East & Africa